These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4210304)

  • 1. A simple procedure for the isolation of IgG anti-nuclear antibodies from human serum.
    Fritzler MJ; Watson JI; Church RB
    Clin Biochem; 1974 Jun; 7(2):179-85. PubMed ID: 4210304
    [No Abstract]   [Full Text] [Related]  

  • 2. Patterns of nuclear fluorescence and DNA-binding activity.
    Luciano A; Rothfield NF
    Ann Rheum Dis; 1973 Jul; 32(4):337-41. PubMed ID: 4580007
    [No Abstract]   [Full Text] [Related]  

  • 3. Combined titre and fluorescent pattern of IgG antinuclear antibodies using cultured cell monolayers in evaluating connective tissue diseases.
    Parker MD; Kerby GP
    Ann Rheum Dis; 1974 Sep; 33(5):465-72. PubMed ID: 4608364
    [No Abstract]   [Full Text] [Related]  

  • 4. Treponemal antibodies in non-syphilitic, positive anti-nuclear factor sera.
    Neblett TR; Burnham TK; Merriam LR; Fine G
    J Invest Dermatol; 1966 Jan; 46(1):84-90. PubMed ID: 5324225
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of anti-agalactosyl IgG antibodies, rheumatoid factors, and anti-cyclic citrullinated peptide antibodies in the differential diagnosis of rheumatoid arthritis and its mimics.
    Lu MC; Hsieh SC; Lai NS; Li KJ; Wu CH; Yu CL
    Clin Exp Rheumatol; 2007; 25(5):716-21. PubMed ID: 18078619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinucleolar antibodies. Their frequency and diagnostic association.
    Ritchie RF
    N Engl J Med; 1970 May; 282(21):1174-8. PubMed ID: 4909324
    [No Abstract]   [Full Text] [Related]  

  • 7. Analyses of lymphocytes from patients with rheumatoid arthritis and systemic lupus erythematosus. Occurrence of interfering cold-reactive antilymphocyte antibodies.
    Winchester RJ; Winfield JB; Siegal F; Wernet P; Bentwich Z; Kunkel HG
    J Clin Invest; 1974 Nov; 54(5):1082-92. PubMed ID: 4138924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of nuclear immunofluorescent patterns.
    Dorsch CA; Gibbs CB; Stevens MB; Shulman LE
    Ann Rheum Dis; 1969 May; 28(3):313-9. PubMed ID: 4890805
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunologic diagnosis and differential diagnosis of Lupus erythematosus].
    Herrmann WP
    Hautarzt; 1974 May; 25(5):209-11. PubMed ID: 4605720
    [No Abstract]   [Full Text] [Related]  

  • 10. The immunofluorescent tumor imprint technique. IV. The significance of "thready" nuclear immunofluorescence.
    Burnham TK; Neblett TR; Fine G; Bank P
    Arch Dermatol; 1969 May; 99(5):611-6. PubMed ID: 4889089
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of anti-citrullinated filaggrin antibodies as hallmarks for the diagnosis of rheumatic diseases.
    Dubucquoi S; Solau-Gervais E; Lefranc D; Marguerie L; Sibilia J; Goetz J; Dutoit V; Fauchais AL; Hachulla E; Flipo RM; Prin L
    Ann Rheum Dis; 2004 Apr; 63(4):415-9. PubMed ID: 15020336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of antinuclear antibodies, anti-DNA antibodies, C 3 complement factor and IgG in lupus erythematosus and rheumatoid arthritis].
    Lehmann C; Hurtado R; Valdivieso M; Godoy G; Sorensen R
    Rev Med Chil; 1972; 100(5):485-9. PubMed ID: 4114175
    [No Abstract]   [Full Text] [Related]  

  • 13. The presence of antibodies against extractable nuclear antigens in serum: a comparison of immunoblotting versus radial immunodiffusion.
    Uyttenbroeck W; Cooreman W; Scharpe S
    Ann Clin Biochem; 1993 Jan; 30 ( Pt 1)():83-6. PubMed ID: 8434872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lupus erythematosus cell phenomenon: mechanisms and significance.
    Zweiman B; Hebert J
    Int J Dermatol; 1976 Mar; 15(2):121-4. PubMed ID: 56315
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of T cell subtyping to distinguish rheumatoid arthritis from systemic lupus erythematosus.
    Traycoff RB; Rogers WW; Gregory SA
    J Rheumatol; 1981; 8(3):494-7. PubMed ID: 6974781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of anti-citrullinated peptide and anti-RA33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis.
    Mediwake R; Isenberg DA; Schellekens GA; van Venrooij WJ
    Ann Rheum Dis; 2001 Jan; 60(1):67-8. PubMed ID: 11114286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA antibodies detected by microhemagglutination test in the diagnosis of systemic lupus erythematosus.
    Depiante-Depaoli M; Riera CM; Yantorno C; Risemberg A; Strussberg A
    J Immunol Methods; 1978; 22(1-2):149-53. PubMed ID: 353200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fluorescent treponemal antibody absorbed (FTA-ABS) test beading phenomenon in connective tissue diseases.
    McKenna CH; Schroeter AL; Kierland RR; Stilwell GG; Pien FD
    Mayo Clin Proc; 1973 Aug; 48(8):545-8. PubMed ID: 4578169
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficient evaluation of humoral immune responses by the use of serum pools.
    Sternbæk L; Draborg AH; Nielsen CT; Jacobsen S; Iversen LV; Troelsen L; Theander E; Houen G
    J Immunol Methods; 2017 Apr; 443():1-8. PubMed ID: 28130033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The differential diagnostic significance of the binding capacity of serum immunoglobulins with amino acids in rheumatism, rheumatoid arthritis and systemic lupus erythematosus with a minimal degree of activity].
    Amosova EN; Fedorich VN; Zamulko AA
    Lik Sprava; 1994 Feb; (2):20-3. PubMed ID: 8073710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.